Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outpatient, Liquid Aspirin to Reduce COVID-19 Hospitalizations

NCT04937088 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center in New Orleans as lead sponsor.

NCT NCT04937088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04937088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outpatient, Liquid Aspirin to Reduce COVID-19 Hospitalizations
Lead sponsor
Louisiana State University Health Sciences Center in New Orleans
Phase
Phase 2
Overall status
Unknown status
Start date
December 6, 2021
Completion date
December 5, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19